| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 39.10B | 34.72B | 36.73B | -2.69B | 64.45B |
| Gross Profit | 13.13B | 13.39B | 11.12B | 11.06B | 12.93B |
| EBITDA | 5.64B | 5.93B | 3.98B | 4.96B | 4.72B |
| Net Income | 4.12B | 4.07B | 2.87B | 3.73B | 3.26B |
Balance Sheet | |||||
| Total Assets | 862.83B | 802.16B | 713.23B | 701.46B | 630.49B |
| Cash, Cash Equivalents and Short-Term Investments | 28.39B | 24.71B | 19.38B | 18.84B | 17.23B |
| Total Debt | 13.41B | 10.23B | 9.65B | 11.29B | 9.73B |
| Total Liabilities | 829.83B | 771.01B | 683.38B | 669.14B | 600.00B |
| Stockholders Equity | 29.86B | 29.54B | 26.84B | 29.01B | 27.22B |
Cash Flow | |||||
| Free Cash Flow | 2.71B | 4.75B | 5.20B | 7.05B | 10.37B |
| Operating Cash Flow | 2.71B | 4.75B | 5.20B | 7.05B | 10.37B |
| Investing Cash Flow | -56.00M | -408.00M | -786.00M | -5.49B | -11.21B |
| Financing Cash Flow | -4.32B | -2.29B | -3.55B | -620.00M | -992.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | C$40.63B | 13.48 | 12.83% | 3.28% | -9.03% | 44.14% | |
74 Outperform | C$44.02B | 15.12 | 16.27% | 1.86% | 2.51% | 44.44% | |
69 Neutral | C$47.61B | 12.88 | 14.68% | 4.11% | -19.88% | -13.92% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | C$78.09B | 14.68 | 11.34% | 3.49% | 5.46% | 10.52% | |
66 Neutral | $50.85B | 8.56 | 18.65% | 0.84% | 10.08% | 24.18% | |
65 Neutral | C$56.79B | 15.18 | 13.98% | 3.62% | -20.64% | 14.88% |
Great-West Lifeco Inc. said President and Chief Executive Officer David Harney will participate in a virtual fireside chat hosted by TD Cowen analyst Mario Mendonca on February 19, 2026, to discuss the company’s strategy and 2025 financial results. A replay of the webcast will be made available in the events section of the company’s website after the session and archived online for 90 days, offering investors and other stakeholders extended access to management’s commentary.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$70.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco reported record base earnings for 2025, with fourth-quarter base earnings rising 12% to $1.25 billion, or $1.36 per share, driven by higher assets from market growth, strong performance in its Retirement and Wealth segments, particularly at Empower, and new business in Capital & Risk Solutions. Despite a 6% decline in quarterly net earnings to $1.05 billion and largely flat full-year net earnings, the company delivered an 18.2% base return on equity, maintained a strong LICAT ratio of 128% and $2.1 billion in cash, raised its quarterly dividend by 10% to $0.67 per share, and continued significant share repurchases, underscoring disciplined capital deployment and financial flexibility for shareholders.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$70.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Canada Life and Canada Life Investment Management Ltd. secured 38 FundGrade A+ Awards from Fundata for 2025, with four mutual funds and 34 segregated funds recognized for consistent, outstanding, risk-adjusted performance. The accolades, spanning Canadian, U.S., international and emerging markets equity as well as balanced and fixed income portfolios, underscore the strength of the firm’s investment teams and sub-advisors and reinforce its strategy to become a leading wealth provider in Canada by expanding access to advice and high-performing solutions for advisors and their clients.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$70.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco Inc. will release its fourth-quarter 2025 financial results after markets close on February 11, 2026, followed by an earnings conference call and webcast with company management on the morning of February 12. The scheduled disclosure and investor call underscore the company’s ongoing efforts to communicate financial performance and strategic progress to shareholders and the broader market, providing stakeholders with updated insight into the operations of one of North America and Europe’s major diversified financial services groups.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$60.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco Inc. announced the result of a conversion election for its Non-Cumulative 5-Year Rate Reset First Preferred Shares, Series N. Holders of 6,425 Series N Shares opted to convert their shares into Series O Shares on a one-for-one basis by December 31, 2025. However, due to insufficient conversions to meet the threshold for outstanding Series O Shares, no Series N Shares will be converted to Series O Shares, and written notice will be issued to stakeholders accordingly. This decision underscores operational clarity in managing share conversions and may affect stakeholders holding Series N Shares.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$67.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco Inc. announced the dividend rates for its Non-Cumulative 5-Year Rate Reset First Preferred Shares, Series N, and Non-Cumulative Floating Rate First Preferred Shares, Series O. The fixed dividend rate for Series N Shares is set at 4.090% per annum for the five-year period starting December 31, 2025, while the floating rate for Series O Shares is 3.518% per annum for the period starting on the same date. This announcement provides clarity on the financial returns for investors holding these shares and underscores the company’s commitment to offering competitive financial products, potentially impacting its market positioning and attractiveness to investors.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$67.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.